| Product description : |
Flutamide is a non-steroidal androgen antagonist, which belongs to acylaniline and is a first-line treatment for prostate cancer. It was first designed and synthesized by Schering-Plough in USA and first marketed in USA in 1989 as a treatment for prostate cancer. Due to he amine itself without any hormone activity, good effect in treatment of prostate disease, and cardiovascular and Chemicalbook had no effect on blood vessels, and can keep the patient's sexual function, currently in Europe and the United States has become the common treatment for prostate cancer and prostate hyperplasia and drugs, at the same time can also be used to the prostate disease associated with androgen, all have a lot of research in the world. Moreover, the incidence of adverse reactions of flutamide is low, and patients can well tolerate the low dose multiple times orally, so it is widely used. |
